Pharmaceutical Suppositories Market Overview
Increasing expenditure on the healthcare sector in developed countries and the geriatric population drives the pharmaceutical suppositories market. The rectal route is an excellent drug delivery option in these populations. Due to benefits such as quick absorption of various low molecular weight drugs and the potential for absorption into the lymphatic system, increased demand for suppositories is expected to boost market growth during the forecasted period.
Pharmaceutical Suppositories Market Dynamics
The aging population is a major driver of the growth of the pharmaceutical suppositories market. The global population aged 60 and over is expected to nearly double from 12% to 22% between 2015 and 2050. This means that there will be a larger number of people who are more likely to suffer from chronic diseases, such as cancer and pain, which are commonly treated with suppositories.
Suppositories are a convenient and effective way to deliver medication to the body. They are especially useful for people who have difficulty swallowing pills or who cannot take oral medications due to their illness. Suppositories are also absorbed into the bloodstream more quickly than oral medications, which can make them a more effective treatment option for some conditions.
For More Insights Download Sample
The growing demand for suppositories for the treatment of chronic diseases is expected to drive the growth of the pharmaceutical suppositories market in the coming years. Additionally, the increasing geriatric population is also expected to contribute to the growth of the market.
Pharmaceutical Suppositories Market Segmentation Analysis
By Type
- Rectal Suppositories
- Vaginal Suppositories
- Urethral Suppositories
By Base
- Fatty Base
- Water Miscible Bases
- Emulsifying Bases
By End-User
- Hospitals
- Clinics
- Home Care
- Nursing Home
- Others
By Region
- North America
- South America
- Europe
- Asia Pacific
- Middle East and Africa
Major Companies Covered
Pfizer Inc, Bliss Gvs Pharma Ltd, Cadila Healthcare Ltd, Church And Dwight UK Ltd, Glenmark Pharmaceuticals Limited, Cosette Pharmaceuticals Inc, Intas Pharmaceuticals Ltd, Novartis International AG and Sanofi.
About us
DataM Intelligence 4 Market Research is a premier market research and business consulting firm that empowers businesses with accurate, reliable, and real-time market data and insights across a wide range of industries. Established in 2017, we have collaborated with over 750 companies, delivering valuable market intelligence for more than 6000 markets. Our expertise, extensive industry coverage, and robust research methodology have earned us the trust of our clients, making us their go-to partner for market intelligence needs.
At DataM Intelligence, we provide comprehensive, insightful, and actionable market intelligence, helping businesses navigate complex market landscapes and make informed decisions. Our dedicated team of analysts and industry experts possess in-depth knowledge and experience in their respective fields, ensuring the highest levels of accuracy and data integrity. Choose DataM Intelligence for all your market research and business consulting needs and experience the difference our commitment to excellence can make for your business.
Media Contact
Company Name: DataM Intelligence
Contact Person: Mahalaxmi Bhaira
Email: info@datamintelligence.com
Phone:+1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/
